Delivery Order #SPE2DR26F0N15

Short-Term Delivery Order for Novolog Insulin by AmerisourceBergen

This award represents a short-term delivery order contract issued under a long-term pharmaceutical supply indefinite delivery vehicle held by AmerisourceBergen Drug Corp. AmerisourceBergen, a prominent drug distribution company, specializes in providing essential pharmaceuticals and healthcare products, supporting government healthcare needs. The delivery order procures a specific pharmaceutical product, Novolog insulin in 100 units per milliliter vials, which is critical for managing diabetes among patients served by public health programs. The contract's scope includes timely delivery of this vital medication within a very brief performance window, ensuring continuity of care. This delivery order was placed as a task under the existing indefinite delivery contract, which was competitively secured to guarantee a stable pharmaceutical supply for the government. The award reflects a commitment to maintaining uninterrupted access to critical diabetes treatments. The order's performance period is brief, spanning approximately one day, signifying a rapid-response supply operation. The parent contract is a long-term agreement that underpins reliable pharmaceutical procurement for an extended timeframe, enhancing preparedness and healthcare outcomes in the public sector.

Description

4570810034!NOVOLOG 100 UNIT/ML VIAL 10ML

View original record